⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiospirone SCHEMBL78696 | 1.00 | — | — | |
| Tiospirone SCHEMBL122406 | 0.99 | — | — | |
| SCHEMBL13532488 | 0.99 | — | — | |
| Tiospirone SCHEMBL11081111 | 0.98 | — | — | |
| SCHEMBL10471393 | 0.90 | HTR1A (0.64) | — | |
| SCHEMBL11077375 | 0.88 | HTR1A (0.69) | — | |
| SCHEMBL10520426 | 0.86 | — | — | |
| SCHEMBL10471021 | 0.86 | HTR1A (0.61) | — | |
| SCHEMBL11075546 | 0.86 | HTR1A (0.66) | — | |
| SCHEMBL9413636 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3706762-B1 | N4-HYDROXYCYTIDINE DERIVATIVE AND ANTI-VIRAL USES RELATED THERETO | UNIV EMORY (US) | 2024-10-16 | — | — | EP | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| US-20260124226-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260102422-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260077139-A1 | SPACER DEVICE WITH FLOW RATE SPIROMETER | AEROVU TECHNOLOGIES, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4705284-A1 | 4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | Emory University (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12551497-B2 | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | EMORY UNIVERSITY (US) | 2026-02-17 | — | — | US | disclosed |
| US-12521426-B2 | Methods and compositions for inhibiting glyoxalase 1 (GLO1) | PALMER ABRAHAM (US) | 2026-01-13 | — | — | US | disclosed |
| US-12514993-B2 | Spacer device with flow rate spirometer | AEROVU TECHNOLOGIES, INC. (US) | 2026-01-06 | — | — | US | disclosed |
| WO-2025235664-A1 | PURINE NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20250339374-A1 | BONDED MICROPARTICULATES PREPARATION AND APPLICATIONS THEREOF | VENKOR CORP (US) | 2025-11-06 | — | — | US | disclosed |
| US-11331331-B2 | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | EMORY UNIVERSITY (US) | 2022-05-17 | — | — | US | disclosed |
| EP-3194033-B1 | SPACER DEVICE WITH FLOW RATE SPIROMETER | AEROVU TECH INC (US) | 2022-05-04 | — | — | EP | disclosed |
| US-11278595-B2 | Peptides comprising non-natural amino acids and methods of making and using the same | LONGEVITY BIOTECH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-11274158-B2 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| US-20220062194-A1 | Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors | OMEROS CORP (US) | 2022-03-03 | — | — | US | disclosed |
| US-11241420-B2 | Compositions and methods for prophylaxis and treatment of addictions | OMEROS CORPORATION (US) | 2022-02-08 | — | — | US | disclosed |
| US-11236053-B2 | NADPH oxidase inhibitors and uses thereof | EMORY UNIVERSITY (US) | 2022-02-01 | — | — | US | disclosed |
| EP-3941916-A1 | PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, AND USES RELATED THERETO | Emory University (US) | 2022-01-26 | — | — | EP | disclosed |
| EP-2286797-B2 | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | VECTURA LTD (GB) | 2022-01-26 | — | — | EP | disclosed |